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Abstract
In this paper we present our study of carbamazepine solubility in supercritical carbon
dioxide. We have calculated the solubility values along two isochores corresponding to the
CO2 densities ρ = 1.1ρcr(CO2) and ρ = 1.3ρcr(CO2), where ρcr(CO2) is the critical density
of CO2, in the temperature range from 313 to 383 K, as well as along three isotherms
at T = 318, 328 and 348 K by an approach based on the classical density functional
theory. The solubility values were also obtained using in situ IR spectroscopy and molecular
dynamics simulations along the mentioned isochores and isotherms, respectively. Because
the density functional theory only takes into account the Lennard-Jones interactions, it can
be expected to underestimate the solubility values when compared to the experimental ones.
However, we have shown that the data calculated within the classical density functional theory
qualitatively reproduce the solubility trends obtained by IR spectroscopy and molecular
dynamics simulation. Moreover, the obtained position of the upper crossover pressure is in
good agreement with the experimental literature results.
Keywords: classical density functional theory; molecular dynamics simulation; infrared
spectroscopy; quantum chemical calculations; solubility; carbamazepine
1. Introduction
Nowadays a large part of the drugs presented on the pharmaceutical market are classified
as Class II, according to the Biopharmaceutics Classification System (BCS) [1, 2, 3], i.e.
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demonstrate high intestinal permeability and low aqueous solubility. Such characteristics
can become the reason for refusing from the production of a potentially efficient active
pharmaceutical ingredient (API) during its development phase.
A number of approaches have been developed to deal with the poor drug solubility
and/or dissolution issues, and at the same time to preserve the pharmacological effect of
the compound. They include particle size reduction, formation of amorphous forms, salts,
solvates or cocrystals [1, 4, 5, 6, 7]. Modern micronization techniques utilize specific properties
of supercritical fluids, most frequently supercritical carbon dioxide (scCO2) because of its
favorable characteristics for process design. These approaches can be divided into three
general groups, where scCO2 acts as a solvent, as an antisolvent (co-antisolvent), and as
an additive. Each group has its own advantages and disadvantages (Table 6 in [1]), and
the choice of the method is highly dependent on the compound ability to dissolve in scCO2.
Thus, the knowledge of the drug compound solubility in the scCO2 medium is highly valuable
for the technological process of the development of a bioactive compound and its potential
pharmaceutical applications. However, whether it is an experimental or a computational
scheme, most of the conventional approaches, used to obtain information about the solubility
of a given drug compound in the supercritical fluid (SCF), are time-consuming and resource-
intensive. Recently [8], we have proposed a technique for computing solubility values based
on the calculation of the drug molecule solvation free energy in scCO2 within the classical
density functional theory (cDFT). There we demonstrated the capability of our approach to
qualitatively predict the solubility of ibuprofen in scCO2 and the pressure values, at which
we observe changes in the solubility dependence on temperature at a constant pressure value
(pressure crossovers). The calculated solubility values were lower than the experimental ones.
The observed discrepancies were attributed to the neglecting of the electrostatic interactions
in the framework of the cDFT.
In the present paper, we would like to show the results of our study of carbamazepine
(CBZ) solubility in scCO2. CBZ is an essential anticonvulsant and antiepileptic representative
[9, 10], also used in the treatment of bipolar disorders [11]. It features on the World Health
Organization’s List of Essential Medicines [12] and at the same time belongs to Class II of the
BCS [13], i.e. demonstrates high permeability and poor solubility in water. Although there
is a fair number of papers featuring CBZ, the solubility data in scCO2 for this compound are
practically non-existent in literature (the paper, which we will refer to most is an experimental
study by Yamini et al [14]). The paper is structured as follows: the second section describes
the theoretical approach, in the third one we describe the MD simulation details, in the forth
- our experimental measurements, and then we discuss the obtained results.
2. cDFT-based solubility estimation methodology
For the theoretical prediction of CBZ solubility we utilized the methodology discussed in
depth in our recent papers [8]. Here we shortly describe it.
We use the following relation to determine the solubility [15], which is based on the
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equilibrium condition between the solute’s solid and solution phases:
y2 ≈ p
sat
ρbkBT
exp(βνs[p− psat]− β∆Gsolv), (1)
here ρb is the bulk density of scCO2, kB is the Boltzmann constant, T is the temperature, p is
the total pressure imposed in the system, β = (kBT )−1; νs and psat are the molar volume and
saturation pressure of the pure solute solid phase, respectively, and ∆Gsolv is the solvation
Gibbs free energy of the solute molecule in the scCO2 medium. As is seen, one has to know
the sublimation parameters of the solute and its solvation free energy to obtain the solubility
values. Within our methodology, the data on the solute sublimation, i.e. the molar volume
and saturation pressure values, is supposed to be taken from the experimental data available
in literature, whereas the solvation free energy is computed with the aid of the cDFT.
We start the calculation of the solvation Gibbs free energy from writing down the grand
thermodynamic potential for the scCO2 fluid in the external potential field with the potential
energy Vext(r):
Ω[ρ(r)] = kBT
∫
drρ(r)[ln(Λ3ρ(r))− 1] + Fex[ρ(r)] +
∫
drρ(r)(Vext(r)− µ), (2)
where the first contribution is the Helmholtz free energy of the ideal gas, the second one is
the excess Helmholtz free energy of the fluid, Λ is the thermal de Broglie wavelength, µ is
the chemical potential of the bulk phase at the chosen state parameters.
The CO2 particles are considered as spherically symmetric particles interacting through
the effective pairwise Lennard-Jones (LJ) potential with the parameters defined as εff
and σff and the distance of the cut-off rc = 5σff . The potential can be divided into two
parts, corresponding to the contributions of the hard-core interactions and the attractive
interactions between the molecules of the fluid, at its minimum rm = 2
1
6σff according to
the Weeks-Chandler-Andersen (WCA) procedure [16]. In this respect, the total excess free
energy can be written as follows:
Fex[ρ(r)] = Fhs[ρ(r)] + Fatt[ρ(r)]. (3)
The hard spheres’ contribution (the first term in the right hand side of (3)) is determined
utilizing Rosenfeld’s version of the fundamental measure theory (FMT) [17] as follows:
Fhs[ρ(r)] = kBT
∫
drΦ(r), (4)
where Φ(r) is the excess free energy density (expressed in kBT units), which is the function
of the weighted densities nα(r) =
∫
dr′ρ(r′)ω(α)(r − r′), which, in their turn, are defined
by the weight functions ω(α)(r). The latter characterize the geometric properties of the
hard spheres. Defining expressions for them can be found in the review by R. Roth [18].
The Barker-Henderson (BH) diameter of the hard sphere is determined within the Pade
approximation [19].
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The attractive contribution to the excess free energy is described within the mean-field
approximation:
Fatt[ρ(r)] =
1
2
∫
drρ(r)
∫
dr′ρ(r′)φWCA(r− r′), (5)
where the effective WCA pair potential of attractive interactions is:
φWCA(r) =
 −εff , r < rm4εff [(σffr )12 − (σffr )6
]
, rm < r < rc.
(6)
The solute molecule is modeled as an external LJ potential:
Vext(r) = 4εsf
[(
σsf
r
)12
−
(
σsf
r
)6]
, (7)
where the effective parameters of the interaction between this molecule and the molecules
of the fluid are determined through the Berthelot-Lorenz mixing rules: σsf = (σss + σff )/2
and εsf =
√
εssεff . The parameters of the interactions between the two molecules of the
active compound (σss, εss) and two molecules of CO2 (σff , εff) can be obtained by fitting
the respective parameters of the liquid vapour critical point. One can find the values of the
critical temperature and density for CO2 at NIST [20]. We took the values for the CBZ
critical temperature and pressure from the paper by Li et al [21]. The values of all the
parameters are presented in Table 1.
Table 1: The values of the parameters used to calculate the solubility.
value source
εff 218.73 K this study
σff 0.336 nm this study
εss 565.91 K this study
σss 0.718 nm this study
εsf 351.83 K this study
σsf 0.527 nm this study
Tcr(CO2) 304.13 K [20]
ρcr(CO2) 10.62 mol/l [20]
Tcr(CBZ) 786.83 K [21]
Pcr(CBZ) 25.71 bar [21]
ν(CBZ) 0.18048 m3/mol [21]
psat(CBZ) ln psat = 32.7− 13343/T [22]
To obtain the density profile of the fluid, one has to take a variational derivative of the
grand thermodynamic potential with respect to the density and iteratively compute the
Euler-Lagrange equation:
δΩ[ρ(r)]
δρ(r) = 0, (8)
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which leads to the following expression for density:
ρ(r) = ρb exp
µex(ρb, T )− c(1)fmt(r)− ∫ dr′ρ(r′)φWCA(r− r′)− Vext(r)
kBT
 , (9)
where µex is the excess chemical potential of the bulk phase, c(1)fmt(r) = δFhs[ρ(r)]/δρ(r) is
the one–particle direct correlation function of the hard-sphere system within FMT.
Finally, one can compute the solvation Gibbs free energy of the solute molecule in the
scCO2 medium as the excess grand thermodynamic potential as follows:
∆Gsolv = Ω[ρ(r)]− Ω[ρb]. (10)
Then, turning back to Eq. (1), we can obtain the solubility values after calculating
the solvation free energy. The values of the sublimation pressure were obtained, using the
empirical relation, presented in the work by Drozd et al [22], and the molar volume of the
compound was taken from the paper by Li et al [21] (Table 1).
3. MD simulation and quantum chemical calculations
The CBZ solubility in scCO2 was also estimated by MD simulation, through the same
Eq. (1) with the same input parameters characterizing the solute sublimation and then by
calculating the solvation free energy within the Bennett Acceptance Ratio (BAR) method
[23]. Such choice was motivated by the fact that, as it was demonstrated [24, 25], the BAR
method seems to be significantly more effective than the others, when it comes to more
realistic modeling tests. Within this method one usually needs to perform a decent number
of simulations, each corresponding to a certain intermediate step with its own coupling
parameters λ, resulting in large computational costs [26]. Then one obtains the solvation free
energy values by the summation of all such transitionary stages from the full solute-solvent
interaction coupling to none. We used the following pairwise potential of the interaction
between the particles to compute the solvation free energy:
Uij(λLJ , λC) = λLJ × 4εij
[(
σij
r
)12
−
(
σij
r
)6]
+ λC × qiqj
r
, (11)
where λLJ and λC are, respectively, the alchemical scaling parameters of Lennard-Jones
and Coulombic interactions; qi, qj are the atomic charges, εij and σij are the Lennard-Jones
parameters of the solute-solvent interaction. We obtained these parameters through the
Berthelot-Lorenz mixing rules: σij = (σii + σjj)/2, εij =
√
εiiεjj. The simulation was
performed in the Gromacs 4.6.7 package [27]. For each computation of the solvation free
energy 12 independent simulations were performed, each with its own potential energy (Eq.
(11)), corresponding to a certain pair of the coupling parameters. The following set of
the alchemical coefficients {λLJ , λC} was chosen: {0.0, 0.0}, {0.2, 0.0}, {0.5, 0.0}, {1.0, 0.0},
{1.0, 0.2}, {1.0, 0.3}, {1.0, 0.4}, {1.0, 0.5}, {1.0, 0.6}, {1.0, 0.7}, {1.0, 0.8}, {1.0, 1.0}; here
0.0 and 1.0 denote the fully decoupled and fully coupled interactions between the solute
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and solvent particles, respectively. The structure of the CBZ molecule was taken from
the Automated Topology Builder (ATB) [28]. We used GROMOS 54A7 force-field [29] for
intramolecular CBZ interactions and the Lennard-Jones contribution of intermolecular ones.
The atomic partial charges of CBZ were developed based on the Merz-Kollman method
[30, 31], using Gaussian 09 software [32] with the PBE functional and 6-311++g(2d,p) basis
set. The atomic partial charges were averaged over two CBZ conformers (Fig.1, Table 2).
Figure 1: CBZ molecule structure.
The interaction potential for the carbon dioxide molecule corresponds to Zhang’s one [33].
The MD simulation parameters are the same as in the work by Paliwal and Shirts [34] for
the case of the methane solvation free energy calculation, except for the case of the barostat
choice, as we used Parinello-Rahman pressure coupling. Each simulation was performed for
100 ps in the NVT ensemble with a step of 1 fs, for 1 ns in the NPT ensemble with a step of
2 fs and for 10 ns of the production run simulation in the NPT ensemble with a step of 2 fs.
We used the experimental data from Yamini’s paper [14] as the basis and computed two
isotherms at 328 and 348 K with pressures corresponding to those presented in the paper.
4. Infrared spectroscopy experiment
We also measured experimentally the solubility of CBZ in scCO2 using in situ infrared
spectroscopy. The obtained values were compared with those obtained by MD and cDFT
methods as well as with those obtained by Yamini [14].
The experimental solubility values are generally given in the form of solubility isotherms.
However, in our in situ IR experiment, we measured the solubility along the isochores,
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Table 2: Calculated partial charges.
number atom charge number atom charge
1 H1 0.364805 16 H6 0.148109
2 N1 -0.815994 17 C8 0.276173
3 H2 0.330523 18 C9 -0.322119
4 C1 0.709618 19 H7 0.152478
5 O -0.568671 20 C10 -0.178388
6 N2 -0.305988 21 H8 0.138673
7 C2 0.217946 22 C11 0.162796
8 C3 0.070900 23 C12 -0.217421
9 C4 -0.130436 24 H9 0.132605
10 H3 0.137536 25 C13 -0.116918
11 C5 -0.170959 26 H10 0.126729
12 H4 0.135166 27 C14 -0.129340
13 C6 -0.090339 28 H11 0.130257
14 H5 0.123977 29 C15 -0.222715
15 C7 -0.262720 30 H12 0.173718
because in the experiment we used a high pressure high temperature (HPHT) optical cell
with a constant volume, as it is the case in many supercritical micronization techniques.
In order to measure the solubility (concentration of a saturated solution) of CBZ in scCO2,
we used the approach developed in our previous works [35] [36]. This approach is centered
around the Beer–Lambert law and, in particular, on the usage of the integral extinction
coefficient εint (molar absorption coefficient) value of a chosen analytical spectral band. For
this purpose, we registered the IR spectra of CBZ, dissolved in an inert solvent that had
no specific interactions with the CBZ molecules. The integral extinction coefficient was
calculated by the following formula:
εint =
A
lc
(12)
where l is the optical path length of the sample (cm), c is the molar concentration of the
solute (mol ·ml−1), A is the integral intensity (cm−1). In its turn, the integral intensity is
calculated as follows:
A =
∫ ν2
ν1
log I0(ν)
I(ν) dν, (13)
where ν1 and ν2 are the boundaries of the analytical spectral band, I0 and I are the incident
and transmitted intensities, respectively.
Within the in situ IR approach, the integral extinction coefficient of the C=O vibration
mode of the CBZ chosen as an analytical spectral band was calculated. This band has a good
resolution and high signal–to–noise ratio within the whole studied temperature range. Then
we recorded the IR spectra of the CBZ diluted in tetrahydrofuran (THF) in the temperature
range of 313− 383 K with a step of 10 K. The molar concentration of the prepared solution
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was 1.1755 · 10−2 mol · l−1, which corresponds to the molar fraction of the CBZ value equal
to 9.6012 · 10−4. These spectra were measured on a FTIR spectrometer Bruker VERTEX
80v in the wavenumber range of 1000 − 4000 cm−1 with a resolution of 1 cm−1 using an
HPHT cell [36] with the optical path length l = 0.118 cm. In order to increase the spectral
signal-to-noise ratio, 128 spectra were recorded for each temperature and then they were
averaged out. By subtracting the THF spectra weighted by its corresponding mole faction
from the spectra of the CBZ–THF binary mixture, we obtained the CBZ spectrum (Fig. 2a).
The C=O spectral region corrected for the base line is presented in (Fig. 2b).
Figure 2: IR spectra of the binary mixtures: CBZ – THF (a), CBZ – scCO2 (c). The spectral domain
bounded by a rectangle corresponds to the analytical spectral band of C=O. The analytical spectral band
corrected for the base line contribution for CBZ dissolved in THF (b) and in scCO2 (d).
In order to estimate the value and the standard deviation of the C=O vibration mode
integral intensity for each temperature we measured four spectra with a time interval of 10
minutes. The integral extinction coefficients were averaged for each temperature and the
standard deviation was found to be from 0.2% to 0.05% in the whole studied temperature
range. As it is shown in Fig. 3, the extinction coefficient is described by a linear equation with
a small slope coefficient (tanα = −0.253 km ·mol−1 ·K−1) at a high accuracy (R2 = 0.998).
The linear character of εint = f(T ) confirms the absence of specific intermolecular interactions,
which was shown in one of our previous works [37].
Within this study, the solubility of CBZ in scCO2 was measured along two isochores
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Figure 3: Temperature dependence of integral extinction coefficient and its linear approximation.
corresponding to the density of the fluid phase ρ = 1.1ρcr(CO2) and ρ = 1.3ρcr(CO2)
(ρcr = 10.6249 mol/l is the critical density of CO2) in the temperature range of 313− 383 K
with a step of 10 K. The optical path lengths of the sample for these two measurements
were 0.108 cm and 0.097 cm, respectively. The C=O stretching region of the IR spectra of
CBZ in scCO2, which were measured in the same way as for the CBZ–THF system, was also
analyzed (Fig. 2c,d). These measurements were carried out in a modified high-pressure high-
temperature cell described in our work [38]. There was a difference between the shape of the
C=O vibration bands in CBZ–THF (Fig. 2a,b) and CBZ–scCO2 (Fig. 2c,d) binary systems.
In the case of the former system, the C=O vibration mode was symmetric, while in the latter
system this band was blue shifted and split into two spectral components, whose intensities
and contributions to the total spectral band are sensitive to the temperature increase. We
interpret this splitting as a consequence of the presence of two CBZ conformers in the solution.
Indeed, in the case of the CBZ–scCO2 system, because of the permanent excess of crystalline
CBZ being in contact with the solution phase, there was an equilibrium between the CBZ
solid phase and its saturated solution in scCO2. As it was shown [39, 40, 38, 41, 42, 43],
for drug compounds with different types of polymorphism, there are correlations between
the conformers in a solution and polymorphic modifications of their crystalline forms in the
bottom phase. Thus, keeping in mind that there is an equilibrium between the solution and
the solid phase, one must expect the presence of a conformational equilibrium of the CBZ
molecules in the solution. Indeed, the spectral analysis of the C=O vibration mode in the
CBZ–scCO2 system, carried out based on the results of the quantum chemical calculations,
showed that there were two conformers in the solution phase that were responsible for the
corresponding spectral contributions to the C=O spectral band. A detailed description of
the IR experiment and quantum-chemical calculations was presented in our previous papers
[41, 44]. Therefore, the observed splitting of the analytical spectral band for the CBZ–scCO2
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system is a consequence of the presence of two conformers in the solution.
To calculate the concentration of the CBZ in its saturated solution in scCO2 we used the
value of integral intensity of the C=O vibration band. To obtain this value, we applied a
spectral approximation procedure using Fityk software package [45]. Taking into account the
results of the quantum chemical calculations we used two spectral profiles to reproduce the
analytical spectral band. Therefore, the full integral intensity of the analytical spectral band
was calculated as a sum of these components. Then, the solubility of the CBZ dissolved in
scCO2 as a function of temperature was calculated as follows:
cCBZ(T ) =
A(T )
l · εint(T ) . (14)
The molar fraction of CBZ in a scCO2 solution was calculated according to the equation:
XCBZ =
cCBZ
cCBZ + cCO2
, (15)
where cCO2 is the CO2 density (mol · l−1).
5. Results and discussion
Now we compare the computed and experimental solubility values determined in this
paper as well as by Yamini et al. [14]. The comparison is summarized in Fig. 4.
As it was outlined above, our in situ IR experiment was conducted under the isochoric
conditions, thus, it is rather problematic to make a straightforward comparison. Nevertheless,
we show the solubility values corresponding to three temperatures T = 333 K, T = 343 K
and T = 353 K, close to the state parameters, at which the values were obtained by the
other methods. It should be outlined that the results of the in situ IR experiment correctly
represent the solubility behavior within the crossover region, i.e. the inverse dependence of
solubility on temperature at a given pressure.
All in all, one can observe qualitative agreement between the obtained results. In addition,
it is seen that the trend observed in our previous study of the ibuprofen solubility in scCO2
[8] is the same, i.e. the solubility values obtained according to the cDFT-based approach are
lower than the values from the experiments and MD simulations. This can be correlated
with the fact that, as we have already mentioned, this method does not take into account
the electrostatic contribution to the solvation free energy of the compound in scCO2.
It can be seen from the comparison of the solvation free energy values (Fig. 5a) obtained
by the cDFT-based approach (dashed lines) and by the MD simulation (symbols) at two
temperatures T = 328 K and T = 348 K. The discrepancies between the values of the
solvation free energy correspond to the neglect of the electrostatic contribution within the
cDFT approach. In Fig. 5b we demonstrate that the values of the cDFT-calculated solvation
free energy are in decent agreement with the values of the Lennard-Jones contribution to the
solvation free energy obtained by MD simulation, especially within the crossover region, i.e.
at the pressures approximately from 120 to 200 bar.
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Figure 4: Comparison of the solubility values obtained in accordance with the cDFT approach (solid lines),
MD simulation (dashed lines with empty triangles), our in situ IR spectroscopy measurements (coloured
stars) and the literature data from the experiment by Yamini et al (coloured circles) [14].
Despite the underestimation of the solubility magnitude by the cDFT-based approach,
it is important to note that the position of the upper pressure crossover is approximately
the same for the cDFT, MD simulation and literature results. The reliable value of the
lower pressure crossover for CBZ is hard to determine due to its occurrence in the vicinity
of the fluid critical point. Then the cDFT-based approach can be utilized as a preliminary
stage, used to narrow the working region for the following experimental procedure [46]. For
instance, the estimation of the location of the solubility crossover region can be helpful in
the design of extraction processes based on scCO2 [47].
We compared two isochores, 1.1ρcr and 1.3ρcr obtained from our in situ IR measurements
with the ones computed in accordance with the cDFT approach. The values of the CBZ
concentration in its saturated solution in scCO2, as obtained from the experimental measure-
ments, are shown in Table 3. In Fig. 6 we show a comparison of the solubility data for these
isochores (the coloured symbols are the theoretical results, the empty symbols are the in
situ IR experiment). As it is expected, the outcomes of the cDFT method underestimate
solubility values. The discrepancies in the data are of an order of magnitude for the low
temperature range, but the increase in the temperature leads to a decrease in this difference.
This is due to the fact that the electrostatics contribution decreases with the temperature
increase.
We would also like to discuss the potential limitations and restrictions of the proposed
cDFT-based approach. As the input parameters we need to define the critical temperature and
pressure of the bioactive compound to obtain the parameters of the LJ interaction potential,
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Figure 5: Comparison of the solvation free energy of the compound in scCO2 obtained from cDFT with the
total solvation free energy calculated by MD (a), and with the Lennard-Jones contribution to the solvation
free energy calculated by MD (b).
Table 3: The temperature dependence of the CBZ concentration in the saturated solution in scCO2 and its
molar fraction in scCO2 for two isochores.
Isochore 1.1 Isochore 1.3
T , K p, bar c · 104, mol · l−1 X · 105, m.f. p, bar c · 104, mol · l−1 X · 105, m.f.
313 97.54 2.36 1.71
323 124.00 2.94 2.13
333 131.43 1.93 1.65 151.02 3.71 2.68
343 151.89 2.61 2.23 178.41 5.19 3.76
353 172.43 3.48 2.98 206.02 7.43 5.37
363 193.02 4.96 4.25 233.76 10.75 7.78
373 213.63 7.33 6.27 261.56 16.39 11.87
383 234.25 11.09 9.49 298.41 25.43 18.41
and also find the data for the sublimation pressure and molar volume of the compound,
as it was discussed above. Such task may have some pitfalls. It is clear that the critical
parameters for the API molecule can be determined only through some approximations.
In our case the values of the critical parameters for CBZ taken from the literature were
calculated within the Group Contribution Method [48]. In short, such method relates, in a
certain way, the thermodynamic properties of a compound with its molecular structure. The
thing is that there are a number of such correlations, which can in the end lead to a drastic
divergence, with CBZ being no exception. For example, the value of the critical temperature
is 1197.01 K (Kikic et al [49]) and 786.83 K (Li et al [21]). In principle, one can try to fit
the experimental data of solubility using the potential parameters, but in this case cDFT
would fail to estimate the position of the crossover points. We believe that the possibility
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Figure 6: Comparison of the solubility values for two isochores 1.1ρcr and 1.3ρcr for CBZ in scCO2 obtained
from the cDFT and our in situ IR measurements.
of correct estimation of the pressure crossover is crucial for further applications. Thus, one
has to bear in mind that inaccurate estimation of the compound critical parameters can
lead to incorrect results. Another problem is the accurate determination of the sublimation
pressure values and molar volume of the compound as they also play a crucial role in the
determination of the solubility values. Again, approximate methods do not always seem to
produce decent results [21], as compared with the strict experiment [22].
6. Conclusions and prospects
We have obtained values of CBZ solubility in scCO2 using the experimental in situ IR
approach, MD simulation and theoretical computation. All the obtained results were also
compared with the experimental data available in literature.
We have measured two solubility isochores corresponding to the density of 1.1ρcr and
1.3ρcr via the in situ IR spectroscopy, where the extinction coefficient of the C=O vibration
was first determined in a mixture of CBZ and THF at infinite dilution and at different
temperatures in the range between 313 K and 353 K. This allows an accurate determination
of the solubility using the Beer-Lambert law. We have computed the solvation free energy
of CBZ in scCO2 within the MD simulation for two isotherms: 328 K and 348 K, and
calculated the solubility based on these results. The same isochores and isotherms were
computed according to the theoretical cDFT-based approach. The results of the latter are in
qualitative agreement with the experiment and simulation, and, despite the neglect of the
13
electrostatic solute-solvent interactions, they reproduce the position of the upper pressure
crossover with reasonable accuracy.
In conclusion, we would like to speculate on the possible applications of our cDFT-based
approach. Firstly, this approach could be utilized for predicting the pressure crossover region
within the region of the active compound solubility in scCO2 provided that the sublimation
pressure and the critical parameters for the solute are available. In addition, this approach
can be implemented as a software tool in a possible complex experimental setup of solubility
data treatment along with the in situ IR-based methodology presented above.
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